Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany
Aydin, Inci, May, Marcus, Pisano, Fabio, Mpofu-Maetzig, Nontsikelelo, Grode, Leander, Parekh, Sameer, Pujari, Pramod, Shewale, Sunil, Desai, Shivani, Sharma, Hitt, Rao, Harish, Gautam, Manish, Gairola, Sunil, Shaligram, Umesh
Published in Vaccine (02.11.2023)
Published in Vaccine (02.11.2023)
Get full text
Journal Article